CAS 139434-68-7

N-Benzoyl-2'-O-[(methylthio)methyl]-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]cytidine

Description:

N-Benzoyl-2'-O-[(methylthio)methyl]-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]cytidine is a complex chemical compound characterized by its unique structural features and functional groups. This substance is a modified nucleoside, which means it is derived from cytidine with specific alterations that enhance its properties for potential applications in biochemistry and medicinal chemistry. The presence of a benzoyl group suggests potential for interactions with biological targets, while the methylthio and siloxane moieties may contribute to its stability and solubility. The tetrakis(1-methylethyl) groups indicate a bulky structure, which can influence the compound's steric properties and reactivity. Such modifications are often designed to improve pharmacokinetic profiles, such as absorption and resistance to enzymatic degradation. Overall, this compound's intricate design reflects a strategic approach to developing nucleoside analogs with enhanced therapeutic potential, particularly in the context of antiviral or anticancer research.

Formula: C₃₀H₄₇N₃O₇SSi₂

N-Benzoyl-2'-O-[(methylthio)methyl]-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-cytidine

CAS: 139434-68-7

N-Benzoyl-2'-O-[(methylthio)methyl]-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-cytidine is a synthetic nucleoside that is used as an antiviral. It has been shown to be effective against HIV and HSV. N-Benzoyl-2'-O-[(methylthio)methyl]-3',5'-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-cytidine prevents the synthesis of DNA by inhibiting the enzyme ribonucleotide reductase. It also inhibits the production of deoxyribonucleotides and DNA by binding to the active site of the enzyme DNA polymerase.

Formula: C₃₀H₄₇N₃O₇SSi₂

Purity: Min. 95%

Molecular weight: 649.95 g/mol

Ref: 3D-NB148470